echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Clinical investigation shows that Herb-Pharma's ViroStop spray can effectively reduce the impact of new coronary pneumonia

    Clinical investigation shows that Herb-Pharma's ViroStop spray can effectively reduce the impact of new coronary pneumonia

    • Last Update: 2021-09-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    A recent clinical study showed that the ViroStop antiviral spray from Herb-Pharma in Switzerland can effectively reduce the impact of new coronary pneumonia on patients with mild to moderate symptoms
    .

    ViroStop new crown pneumonia

    The main benefit is that the virus shedding is reduced by 60% after using the therapeutic drug, and the severity of respiratory clinical symptoms is reduced
    .


    This study supports the results of early in vitro tests that polyphenol mixtures can inhibit the growth of viruses in cell culture


    The study included 170 SARS-CoV-2 patients diagnosed by PCR at the General Medical Clinic in Budapest, Hungary from January 15 to May 31, 2021
    .


    These volunteers all had mild to moderate respiratory symptoms.


    Of the 170 volunteers, 86 received a nasopharyngeal spray, the patented ViroStop solution, which contains Cistus and other mixtures rich in polyphenols
    .


    When polyphenols attach to viral proteins, they mechanically inhibit the work of the protein, thereby preventing the virus from entering the cell


    At the end of the study, the level of virus shedding was detected by PCR testing
    .


    The results showed that on day 12, compared with the control group, those patients who started using ViroStop spray from the first day after the test was positive had a nearly 60% reduction in virus shedding


    Compared with the control group, gastrointestinal symptoms were also reduced
    .


    Recent studies have shown that a key factor in the spread of the virus is its ability to multiply in the gastrointestinal tract at the same time


    The team's István Dr.
    Jankovics commented: "The main treatment for the new crown pneumonia, of course, vaccination, but this study implies the use of ViroStop sprays can significantly inhibit the upper respiratory tract of SARS CoV 2-load, thereby to infection provider The opportunity to generate a specific immune response
    .


    "

    Infection immunity

    ViroStop is an over-the-counter treatment medicine made from natural ingredients and can be used safely by children as young as three years old
    .


    In addition, during the course of the study, there were at least three virus variants in Hungary, so it is reasonable to assume that the polyphenol solution and the effect can effectively fight all known mutations of new coronary pneumonia


    Children leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.